About Us
Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers.
-
Regulatory July 21, 2022Vivesto appoints Christer Nordstedt as acting CEO
-
Regulatory July 5, 2022Vivesto winds down its activities in Russia
-
Regulatory June 30, 2022Vivesto appoints Robert Maiorana as acting CFO
Vivesto published its Q1 2022 report on May 25, 2022, at 08.00 am CET.